Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors

NCT: NCT02956291 · COMPLETED

NCT IDNCT02956291
StatusCOMPLETED
Start Date2017-02-15
Completion2025-04-17
SponsorCase Comprehensive Cancer Center (OTHER)
First posted
Last updated

Brief Summary

The purpose of the research study is to test new methods that could improve diagnosis and assessment of brain tumors. One of these methods is a new MR (magnetic resonance) imaging technique called magnetic resonance fingerprinting (MRF), which allows for rapidly scanning the patient and provides quantitative information on tumor tissue. The investigators will compare the data gathered from MR Fingerprinting with other imaging tests, clinical information, treatment details and biopsy results to evaluate the accuracy of this new technique.

Frequently Asked Questions

What is Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors?

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors is a clinical trial registered under NCT02956291. Current status: COMPLETED.

What is the status of NCT02956291?

The current status of NCT02956291 (Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors) is: COMPLETED.

When did Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors start?

Multi-Parametric Quantitative MR Imaging in Evaluation of Brain Tumors started on 2017-02-15.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.